Overview

Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2026-05-01

Target enrollment:

Participant gender:

Summary

The aim of the study is to evaluate simultaneously the immunological and clinical efficacy and tolerability of an influenza vaccine, inactivated, quadrivalent, with cleaved virus, in patients at risk for severe and complicated influenza routinely vaccinated against influenza in family medicine clinics or specialty clinics (pediatric, internal medicine, cardiology, gynecological diabetes, pregnant women, transplant).

Phase:

PHASE4

Details

Lead Sponsor:

Medical University of Warsaw

Treatments:

vaxigrip